Silicon Laboratories, Inc. SLAB
221.24
(0.14)
(0.06%)
as of 25 Sep
- Market cap
- $7.4B
- P/E
- 0.0×
Follow SLAB
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(8.00%) | (5.97%) | (4.65%) | (3.63%) | |
| (6.88%) | (5.21%) | (4.03%) | (3.16%) | ||
ROIC |
(9.49%) | (6.77%) | (5.26%) | (3.88%) | |
Return on Tangible Assets |
(13.54%) | (9.85%) | (7.45%) | (5.77%) | |
Average Days of Receivables |
33.07 | 30.01 | 34.30 | 34.03 | |
Free Cash Flow per Share |
1.86 | 2.01 | 0.53 | (0.16) | |
Free Cash Flow |
61.20 | 65.79 | 17.61 | (5.43) | |
Capital Expenditures |
(36.29) | (29.92) | (34.91) | (38.53) | |
Piotroski F-Score |
5.00 | 5.00 | 5.00 | 6.00 | |
| Other line items | |||||
Cash ROIC |
6.46% | 6.22% | 3.42% | 2.22% | |
Accounts Receivable Turnover |
12.79 | 13.19 | 12.70 | 12.56 | |
Accounts Payable Turnover |
6.53 | 7.04 | 6.07 | 6.10 | |
Inventory Turnover |
2.96 | 3.26 | 3.58 | 3.30 | |
Average Days of Payables |
61.98 | 56.48 | 61.55 | 56.74 | |
Days of Inventory on Hand |
91.55 | 106.42 | 112.70 | 133.54 | |
Tax Rate |
0.03 | 0.12 | 0.17 | 0.22 | |
Research and Development Expense of Revenue |
46.60% | 45.01% | 43.10% | 42.16% | |
Selling, General and Administrative Expense of Revenue |
22.20% | 22.21% | 22.93% | 23.52% | |
Share Based Compensation of Revenue |
10.20% | 10.24% | 9.95% | 10.21% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
(1.13) | (1.47) | (1.04) | (0.85) | |
Depreciation/Fixed assets |
0.32 | 0.30 | 0.26 | 0.25 | |
Capex/Depreciation |
(0.87) | (0.79) | (1.00) | (1.15) | |
Revenue per Share |
22.62 | 23.98 | 24.89 | 25.78 | |
Operating CF per Share |
2.97 | 2.93 | 1.59 | 1.00 | |
Capex per Share |
(1.11) | (0.91) | (1.06) | (1.16) | |
Capex to Sales |
0.05 | 0.04 | 0.04 | 0.05 | |
Net Profit Margin |
(11.58%) | (8.27%) | (6.13%) | (4.57%) |
Columns are period end dates